High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention

We systematically searched in PubMed, Web of Science, Embase and China National Knowledge Infrastructure from the inception to March 31, 2017, identified relevant trials about efficacy of high-does Atorvastatin for patients with percutaneous coronary intervention. Twelve studies with the number of 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Changqing, Jia, Helei, Wang, Zhentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642560/
https://www.ncbi.nlm.nih.gov/pubmed/29050285
http://dx.doi.org/10.18632/oncotarget.19701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642560/
https://www.ncbi.nlm.nih.gov/pubmed/29050285
http://dx.doi.org/10.18632/oncotarget.19701

Ejemplares similares